Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Plasmacytoma × silmitasertib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Plasmacytoma 1 Multiple Myeloma 1 Cholangiocarcinoma 1 Biliary Tract Neoplasms 1 Bile Duct Neoplasms 1

Interventions

Dexamethasone 4 filanesib 2 daratumumab 2 Steroids 2 Injections, Subcutaneous 2 Granulocyte Colony-Stimulating Factor 2 Filgrastim 2 Bortezomib 2 silmitasertib 1 pomalidomide 1 milatuzumab 1 Proteasome Inhibitors 1 Leukapheresis 1 CF regimen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01199718 2011-06-15

Study of CX-4945 in Patients With Relapsed or Refractory Multiple Myeloma

Cylene Pharmaceuticals

Phase 1 Unknown

Multiple Myeloma, Plasmacytoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡